Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum-Reference-Cited by-同舟云学术

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum

Published:2018-02-05 Issue:2 Volume:13 Page:e0192353
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Harmon Andrew W.,Moitra Rituparna,Xu Zhili,Byrnes Andrew P.^ORCID

Funder

U.S. Food and Drug Administration

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide 2017. http://www.wiley.com/legacy/wileychi/genmed/clinical/.

2. Safety and efficacy of gene-based therapeutics for inherited disorders;AW Harmon,2017

3. Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver;NC Di Paolo;Mol Ther,2009

4. The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery;E Lopez-Gordo;Expert Opin Drug Deliv,2014

5. Adenovirus serotype 5 hexon mediates liver gene transfer;SN Waddington;Cell,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and application of adenoviral vectors;Molecular Therapy - Nucleic Acids;2023-12

2. Adenoviruses in medicine: innocuous pathogen, predator, or partner;Trends in Molecular Medicine;2023-01

3. Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo;PLOS Pathogens;2022-09-26

4. Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy;Pharmaceutics;2021-10-08

5. Innate immunity to adenovirus: lessons from mice;FEBS Letters;2019-12